Publication | Closed Access

Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis

Tegumentary LeishmaniasisMedicineAntiparasitic AgentParasitic ProtozoaImmunologyTherapeutic VaccinePolymeric MicellesImmunotherapyPharmacologyLeishmaniasis TreatmentVisceral LeishmaniasisDrug Discovery